Ftse Mib
38.557,19
0,35%
DAX
22.484,92
0,99%
S&P 500
6.013,13
-1,71%
NASDAQ
19.524,01
0,00%
Bitcoin
95.797,28
-0,49%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cyclo Therapeutics Inc (CYTH) Cyclo Therapeutics Inc (CYTH) Notizie

Cyclo Therapeutics Inc

CYTH
0,9098
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 13:04:46
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/2/202514:05BWCyclo Therapeutics Presents Positive Preliminary Data from..
14/1/202514:05BWCyclo Therapeutics to Present at the 21st Annual..
11/12/202413:00GLOBERafael Holdings Reports First Quarter Fiscal 2025 Financial..
14/11/202414:05BWCyclo Therapeutics Reports Third Quarter 2024 Financial..
07/11/202401:14GLOBERafael Holdings Reports Fourth Quarter and Full Year Fiscal..
21/10/202414:00GLOBEPacira BioSciences Appoints Shawn Cross as Chief Financial..
05/9/202415:05BWCyclo Therapeutics Presents Encouraging Preliminary Safety..
26/8/202415:37PRNUSKuehn Law Encourages CYTH, ARCH, CEIX, and VGR Investors to..
22/8/202415:37EDGAR2Form 425 - Prospectuses and communications, business..
22/8/202415:36EDGAR2Form 8-K - Current report
22/8/202412:50BWRafael Holdings and Cyclo Therapeutics Enter Into a..
20/8/202419:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/8/202419:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/8/202419:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/8/202419:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/8/202419:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/8/202419:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/8/202419:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202415:00BWCyclo Therapeutics Reports Second Quarter 2024 Financial..
14/8/202423:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
29/7/202415:05BWCyclo Therapeutics Announces Notice of Decision to Grant..
17/7/202420:35EDGAR2Form 8-K - Current report
25/6/202415:25BWCyclo Therapeutics to Present at the Society for the Study..
14/6/202422:01GLOBERafael Holdings Reports Third Quarter Fiscal 2024 Financial..
30/5/202415:00BWCyclo Therapeutics Achieves Landmark Milestone with..
16/5/202414:05BWCyclo Therapeutics Reports First Quarter 2024 Financial..
18/3/202414:05BWCyclo Therapeutics Reports Full Year 2023 Financial Results..
14/3/202414:34BWCyclo Therapeutics Announces Issuance of U.S. Patent..
13/3/202422:04GLOBERafael Holdings Reports Second Quarter Fiscal 2024 Financial..
04/3/202422:33EDGAR2Form 8-K/A - Current report: [Amend]
Apertura: Min: Max:
Chiusura: 0,9098

La tua Cronologia

NASDAQ
CYTH
Cyclo Therapeutics
USOTC
ARDS
Aridis Pharmaceuticals (CE)
LSE
0Y7Q
Ubs (irl) Etf Plc-msci A...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci